Home - HighTide Therapeutics, Inc.
Pipeline Our focus in the clinic is on advancing our lead candidate, berberine ursodeoxycholate (HTD1801), in chronic metabolic diseases and liver diseases. Based on its dual mechanism of action we are particularly focused on diseases driven by insulin resistance and chronic inflammation. In addition to our lead candidate, we have a growing discovery portfolio. News
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 1.319 |
| 2025-04 | 0.449 |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| hightide | 330 | 3,300 | $0.50 |
| 甘油三酯高 | 22 | 220 | $0.00 |
| hightide therapeutics inc | 16 | 160 | $0.00 |
| t2dm是什么 | 14 | 140 | $0.00 |
| tianwei he | 8 | 80 | $0.00 |